Source:http://linkedlifedata.com/resource/pubmed/id/17763951
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-2-26
|
pubmed:abstractText |
The renin-angiotensin system is suggested to be important in liver fibrogenesis. It induces hepatic stellate cell proliferation and up-regulates transforming growth factor beta-1 (TGF-beta1) expression. Matrix metalloproteinase-2 (MMP-2) is involved in extracellular matrix remodelling. Fibrosis, a consequence of most chronic liver diseases, may be the result of a disturbed balance between fibrogenesis and fibrolysis. The aim of this study was to investigate the effect of enalapril on liver fibrogenesis induced in rats by bile-duct ligation. Forty-seven rats were divided into two groups: bile-duct ligated (BDL) (n = 24) and BDL + enalapril (n = 23). Fibrosis was evaluated by the Knodell scoring system, and TGF-beta1 and MMP-2 were assessed with immunohistochemistry at the second, fourth and sixth weeks after bile-duct ligation. In the BDL group, TGF-beta1 increased by the second week and this increase continued through weeks 4 and 6. In the BDL + enalapril group, TGF-beta1 was significantly lower than the other group (P < 0.05). MMP-2 progressively decreased after week 2 in the BDL group. In the BDL + enalapril group, MMP-2 was significantly higher than the BDL group at the fourth and sixth weeks. These results suggest that enalapril reduces the liver tissue TGF-beta1 and has an ameliorating effect on the fibrosis markers TGF-beta1 and MMP-2.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Enalapril,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Transforming Growth Factor beta1
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0163-2116
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
53
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
789-93
|
pubmed:meshHeading |
pubmed-meshheading:17763951-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:17763951-Animals,
pubmed-meshheading:17763951-Enalapril,
pubmed-meshheading:17763951-Liver,
pubmed-meshheading:17763951-Liver Cirrhosis,
pubmed-meshheading:17763951-Male,
pubmed-meshheading:17763951-Matrix Metalloproteinase 2,
pubmed-meshheading:17763951-Rats,
pubmed-meshheading:17763951-Rats, Wistar,
pubmed-meshheading:17763951-Transforming Growth Factor beta1
|
pubmed:year |
2008
|
pubmed:articleTitle |
Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis.
|
pubmed:affiliation |
Department of Gastroenterology, Faculty of Medicine, Fatih University, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|